Prescription Drug Price Transparency Act established, drug manufacturers required to submit drug price information to the commissioner of health, civil penalties provided, and report required.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2019
Committee Review
Floor Vote
Governor
Introduced Feb 14, 2019
Last action May 11, 2020
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
21
Key actions
5
Committee
7
Amendments
1
Apr 28, 2020
Committee
Joint rule 2.03, Deadlines, re-referred to Rules and Legislative Administration
lower
Apr 28, 2020
Lower · Passed
Committee report, to adopt and re-refer to Ways and Means
lower
Mar 11, 2020
Lower · Passed
Committee report, without further rec to amend, re-refer to Judiciary Finance and Civil Law Division
lower
Feb 27, 2020
Introduced
Division action, to adopt as amended and return to Ways and Means
lower
Mar 18, 2019
Committee
Referred by Chair to Health and Human Services Finance Division
lower
Mar 18, 2019
Lower · Passed
Committee report, to adopt and re-refer to Ways and Means
lower
Mar 11, 2019
Lower · Passed
Committee report, to adopt and re-refer to Judiciary Finance and Civil Law Division
lower
Mar 4, 2019
Lower · Passed
Committee report, to adopt as amended and re-refer to Health and Human Services Policy
lower
Feb 14, 2019
Introduced
Introduction and first reading, referred to Health and Human Services Policy
lower
0 primary · 32 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about HF 1246
Scope: MN
Hi! I can help you understand HF 1246. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline